If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Download FREE Excerpt
52 Info Graphics
42 Data Graphics
7 Best Practices
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Health Care; Pharmaceutical; Diagnostic; Medical Device; Manufacturing; Biotech; Consumer Products; Chemical; Biopharmaceutical; Financial Services; Technology
Abbott; Akron Molecules; Alkem Laboratories; Astellas; AstraZeneca; Baxter; Baxter Healthcare; Bayer; Becton Dickinson; Biogen Idec; BMS; Bracco Diagnostics; Covidien; Cubist Pharmaceuticals; Eisai; Endo Health Solutions; Esteve; Ethicon; Ferring Pharmaceuticals; Forest; Genentech; Gilead; GlaxoSmithKline; Grunenthal; Guerbet; Ipsen; LifeCell; Janssen; MAP Pharmaceuticals; MedImmune; Medtronic; Methapharm; MSD Pharma; Mylan; Novartis; Novo Nordisk; Onyx; Pfizer; Philips Healthcare; Ranbaxy; Roche; Sanofi Pasteur; Shire; Shire HGT; Teva; UCB; Upsher-Smith Labs; Valeant; ViroPharma; Xanodyne
The report is based on the insights of 68 Medical Affairs executives and managers at 50 leading global companies. The benchmark class in this study consists of a Mature Markets and Emerging Markets Segment. The Mature Market Segment includes 41 participants from pharma and 12 device respondents. The Emerging Markets Segment consists of 15 participants working in India, China, Brazil, and Turkey.
Key research objects include: